Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Biomed Pharmacother. 2019 Apr;112:108694. doi: 10.1016/j.biopha.2019.108694. Epub 2019 Feb 22.
Bu-Shen-Yi-Qi formula (BSYQF) could suppress chronic airway inflammation according to previous studies. However, there is relatively little direct experimental evidence to evaluate the effects of BSYQF treatment on airway remodeling in chronic asthma. Recent evidence suggests that oxidative stress is involved in airway inflammation and airway remodeling in chronic asthma. BSYQF which includes various of chemical components having antioxidant effects, could be beneficial in attenuating airway remodeling in chronic asthma. The purpose of this study was to elucidate the effect of BSYQF treatment on airway remodeling and investigate its potential mechanisms in chronic asthma. To develop the murine models of chronic asthma, BALB/c mice were sensitized and challenged to ovalbumin for 8 weeks. BSYQF (5, 10, 20 g raw herbs/kg body weight) or tiotropium bromide (0.1 mM) were administered orally and intranasal instillation, respectively. The effect of BSYQF on pulmonary inflammation and remodeling was evaluated. The parameters of oxidative stress in the lung were analyzed. BSYQF treatment reduced airway hyperresponsiveness (AHR), Th2 response including IL-4, IL-13, and OVA-specific IgE and IgG1, transforming growth factor-β (TGF-β), vascular endothelium growth factor (VEGF), airway inflammation and airway remodeling including smooth muscle thickening and peribronchial collagen deposition. As for oxidative stress, BSYQF treatment reduced reactive oxygen species (ROS), Malondialdehyde (MDA), NO, and the expression of inducible nitric oxide synthase (iNOS), but increased significantly glutathione (GSH) /Oxidized glutathione(GSSH) ratios in the lung, restored mitochondrial ultrastructural changes of bronchial epithelia and ATP levels in the lung. In summary, this study suggested that BSYQF treatment ameliorated airway remodeling and alleviated asthmatic features in chronic asthma models. Anti-inflammatory and antioxidant effect of BSYQF may explain why BSYQF has effects on preventing airway remodeling.
补肺益肾益气方(BSYQF)可抑制慢性气道炎症,这在前些研究中已有报道。然而,直接评估BSYQF 治疗对慢性哮喘气道重塑影响的实验证据相对较少。最近的证据表明,氧化应激参与了慢性哮喘的气道炎症和气道重塑。BSYQF 包含多种具有抗氧化作用的化学物质,可能对减轻慢性哮喘中的气道重塑有益。本研究旨在阐明 BSYQF 治疗对气道重塑的影响,并探讨其在慢性哮喘中的潜在机制。为了建立慢性哮喘的小鼠模型,BALB/c 小鼠用卵白蛋白致敏和激发 8 周。BSYQF(5、10、20g 生药/kg 体重)或噻托溴铵(0.1mM)分别经口灌胃和鼻内滴注给药。评估 BSYQF 对肺炎症和重塑的影响。分析肺内氧化应激参数。BSYQF 治疗可降低气道高反应性(AHR)、Th2 反应(包括 IL-4、IL-13 和 OVA 特异性 IgE 和 IgG1)、转化生长因子-β(TGF-β)、血管内皮生长因子(VEGF)、气道炎症和气道重塑(包括平滑肌增厚和支气管周围胶原沉积)。至于氧化应激,BSYQF 治疗可降低活性氧(ROS)、丙二醛(MDA)、NO 和诱导型一氧化氮合酶(iNOS)的表达,但可显著增加肺中的谷胱甘肽(GSH)/氧化型谷胱甘肽(GSSH)比值,恢复支气管上皮的线粒体超微结构变化和肺中的 ATP 水平。总之,本研究表明,BSYQF 治疗可改善慢性哮喘模型中的气道重塑并减轻哮喘特征。BSYQF 的抗炎和抗氧化作用可能解释了 BSYQF 为何能预防气道重塑。